SCHEMBL4382935

SCHEMBL4382935

O=C(CCCCCCCCc1ccco1)CCCCCCCCc1ccco1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
HPGD P15428 4/20 0.54
TDP1 Q9NUW8 2/20 0.54
CYP3A4 P08684 1/20 0.54
ALOX15 P16050 1/20 0.54
USP2 O75604 1/20 0.54
EPHX2 P34913 3/20 0.46
ALOX5 P09917 1/20 0.42
POLB P06746 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
PTPN7 P35236 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
CHRM2 P08172 1/20 0.41
GLS O94925 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4379184 1.00 ALDH1A1 (0.54) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL5634683 1.00 ALDH1A1 (0.54) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL4373147 1.00 ALDH1A1 (0.54) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL4369185 1.00 ALDH1A1 (0.54) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL11722021 0.87 MAPT (0.55) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL3217675 0.87 ALDH1A1 (0.53) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL8093637 0.87 MAPT (0.55) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL8091454 0.87 MAPT (0.55) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL11912385 0.87 MAPT (0.55) ALDH1A1HPGDTDP1CYP3A4ALOX15
SCHEMBL16124206 0.87 MAPT (0.55) ALDH1A1HPGDTDP1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090162312-A1 NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY 2009-06-25 US claimed
US-20070059273-A1 Novel biodegradable biofouling control coating and method of formulation U.S.A. AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE 2007-03-15 US claimed
US-20090162312-A1 NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY 2009-06-25 US disclosed
US-20070059273-A1 Novel biodegradable biofouling control coating and method of formulation U.S.A. AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070059273-A1 Novel biodegradable biofouling control coating and method of formulation ALG1, CHIT1, BMP2 ALDH1A1 3429/4885HPGD 3451/4885TDP1 3713/4885
US-20090162312-A1 NOVEL BIODEGRADABLE BIOFOULING CONTROL COATING AND METHOD OF FORMULATION ALG1, CHIT1, BMP2 ALDH1A1 3429/4885HPGD 3451/4885TDP1 3713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.